(Q72216463)
Statements
A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients (English)
C E Haug
R B Colvin
F L Delmonico
H Auchincloss
N Tolkoff-Rubin
F I Preffer
R Rothlein
S Norris
L Scharschmidt
766-72; discussion 772-3